This case study examines an 11-year-old boy, Benji, diagnosed with asthma and experiencing a moderate exacerbation. The paper delves into the pathophysiology of asthma, including airway inflammation, mucus secretion, and hyperresponsiveness, leading to symptoms like dyspnea and wheezing. It explores the role of the immune system and inflammatory mediators in asthma development. The case study analyzes Benji's presentation, including increased respiratory rate, accessory muscle use, and tachycardia, and discusses the pharmacological interventions prescribed: Salbutamol, Prednisolone, and Ipratropium. The paper explains the mechanisms of action, pharmacokinetics, and clinical effects of each medication, highlighting their roles in bronchodilation, inflammation reduction, and airway management. The study concludes by emphasizing the importance of addressing the underlying inflammation and providing patient support to manage the exacerbation and prevent further complications.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
